Peptide preparations with prolonged action

Details Peptide preparations with prolonged action Peptide preparations with prolonged action

A - Human Necessities

61

K

167/117, 167/103

A61K 31/56 (2006.01) A61K 9/00 (2006.01) A61K 38/23 (2006.01)

Patent

CA 1098444

Case 4-9910/+ CANADA PEPTIDE PREPARATIONS WITH PROLONGED ACTION Abstract of the Disclosure The invention is directed to calcitonin preparations with prolonged action which are characterized by the presence of a calcitonin with hypocalcemic activity having an isoelectric point in the pH range of about 5 to 9, in the form of a suspension of the sparingly soluble free peptide base in an aqueous or oily liquid. There are used for instance suspensions of Calcitonin M or a derivative or analog thereof, preferably containing 0.1 to 5 mg/ml of the peptide base. The invention also includes a method for the treatment of pathological conditions in humans for whom the administration of a calcitonin is indicated, such as Paget's disease, by administering the suspensions of the invention by the subcutaneous or intramuscular route.

253137

Affiliated with

Also associated with

Rating

Peptide preparations with prolonged action does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide preparations with prolonged action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide preparations with prolonged action will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-986729